In previous studies, we found that the binding of natural compounds to EGFR, causing a decrease in EGFR phosphorylation, inhibited the proliferation, migration, invasion, and angiogenesis of human breast adenocarcinoma cells [41,42]. Here, EGFR is linked to breast adenocarcinoma.